Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jul 2, 2026
Date Accepted: Sep 30, 2026

The final, peer-reviewed published version of this preprint can be found here:

Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study

Kulosman M, Engan HK, Fagerli UM, Reinertsen KV, Sand K, Sandmæl JA, Solberg A, Tandstad T

Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study

JMIR Res Protoc 2026;15:e105443

DOI: 10.2196/105443

PMID: 42956043

Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study

  • Maja Kulosman; 
  • Harald Kåre Engan; 
  • Unn Merete Fagerli; 
  • Kristin Valborg Reinertsen; 
  • Kari Sand; 
  • Jon Arne Sandmæl; 
  • Arne Solberg; 
  • Torgrim Tandstad

ABSTRACT

Background:

Due to advances in cancer diagnostics and treatments, life expectancy after cancer and the number of cancer survivors are increasing. Symptoms and late effects frequently occur in cancer survivors, with a negative impact on functioning and participation in society. Digital health tools might be helpful to systematically assess symptom burden of late effects and rehabilitation needs.

Objective:

To present the planning phase, design and early development of the digital health tool CaReScreen. In additional systematic approach to digital health innovation is demonstrated.

Methods:

The development process of CaReScreen followed an iterative, qualitative and participatory design approach, guided by established frameworks for digital health development. The development process was informed by an exploratory qualitative work with 72 informants across Norway that identified systematic late effect assessment and rehabilitation service navigation as the primary unmet needs in the follow-up of cancer survivors. A 105-item PROM questionnaire (EORTC SURV100 supplemented with five QLQ-C30 items) was selected as the main assessment tool.

Results:

An initial prototype of CaReScreen was developed, consisting of a digital report presenting an original visualisation of the domains from the questionnaires. The visualisation was based on a traffic light scoring system, with green indicating low symptom-burden and high functioning, yellow indicating moderate symptom-burden and moderate functioning and red indicating high symptom-burden and low functioning.

Conclusions:

The CaReScreen Interdisciplinary team have developed an initial digital health tool prototype with the main aim of enabling systematic assessment of late effects and unmet rehabilitation needs.


 Citation

Please cite as:

Kulosman M, Engan HK, Fagerli UM, Reinertsen KV, Sand K, Sandmæl JA, Solberg A, Tandstad T

Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study

JMIR Res Protoc 2026;15:e105443

DOI: 10.2196/105443

PMID: 42956043

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.